Clinical studies of incretin-based therapy in type 1 diabetes: a new approach of antidiabetic drugs? / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 943-949, 2014.
Article
in Chinese
| WPRIM
| ID: wpr-469938
ABSTRACT
Incretin-based therapies are now being widely used in type 2 diabetes as a new type of antidiabetic drugs,with their efficacy and safety having been confirmed.However,there are relatively few researches carried out in type 1 diabetes.A variety of clinical studies (mainly in type 2 diabetes) have shown that incretin-based therapy could effectively improve glucose control.In this article,the clinieal application of incretin-based therapy in type 1 diabetes will be reviewed and commented from the prospective of clinical studies,combined with animal experiments.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Endocrinology and Metabolism
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS